As the leading 3D bioprinting company, CELLINK is committed to providing the most advanced 3D bioprinting products, services and technologies needed to understand and master biology. They develop technologies that provide researchers with the tools they need to create the future of health. Whether it is developing and utilising alternatives to animal models, accelerating drug discovery, rethinking regenerative medicine or developing tissue engineered organs to treat diseases previously considered untreatable.
CELLINK’s bioprinters are based on two bioprinting technologies
